Status:
ACTIVE_NOT_RECRUITING
PLATO - Medication Adherence in Transplant Recipients
Lead Sponsor:
University of British Columbia
Conditions:
Kidney Disease, Chronic
Medication Adherence
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Non-adherence with immunosuppressant drugs is a major reason for premature kidney transplant failure. Currently, patient education and compliance aids (e.g bubble packing) are commonly used to assist ...
Detailed Description
Phase I - Control group. 1. The standard of care will be provided to the control group pre- and post-transplant. This does not involve any direct pre-transplant assessment of medication adherence or ...
Eligibility Criteria
Inclusion
- Kidney transplant candidates anticipated to undergo transplantation from a deceased or living donor within 6 months of enrolment
Exclusion
- There are no exclusion criteria. All eligible patients will be approached by a research assistant. Patients with limited English language fluency will be asked to participate with the assistance of a translator.
Key Trial Info
Start Date :
September 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT04078750
Start Date
September 10 2019
End Date
December 31 2024
Last Update
May 13 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 1M9
2
St. Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6